Commonwealth Equity Services’s Haemonetics HAE Stock Holding History

Commonwealth Equity Services’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$359K	Sell	4,789 -157	-3%	-$10.1K	﹤0.01%	3611
2026 Q1	$279K	Sell	4,946 -1,384	-22%	-$90.1K	﹤0.01%	3699
2025 Q4	$507K	Sell	6,330 -644	-9%	-$43.3K	﹤0.01%	3171
2025 Q3	$340K	Buy	6,974 +961	+16%	+$59.5K	﹤0.01%	3517
2025 Q2	$449K	Buy	6,013 +1,525	+34%	+$101K	﹤0.01%	3239
2025 Q1	$285K	Buy	4,488 +760	+20%	+$51.7K	﹤0.01%	3547
2024 Q4	$291K	Sell	3,728 -93	-2%	-$7.47K	﹤0.01%	3421
2024 Q3	$307K	Buy	3,821 +148	+4%	+$12K	﹤0.01%	3337
2024 Q2	$304K	Buy	3,673 +117	+3%	+$10.3K	﹤0.01%	3275
2024 Q1	$304K	Buy	+3,556	New	+$279K	﹤0.01%	3264
2021 Q3	–	Sell	-55,782	Closed	-$3.72M	–	3624
2021 Q2	$3.72M	Buy	+55,782	New	+$3.95M	0.01%	1020
2019 Q4	–	Sell	-1,737	Closed	-$219K	–	2914
2019 Q3	$219K	Hold	1,737	–	–	﹤0.01%	2490
2019 Q2	$209K	Sell	1,737 -868	-33%	-$85.4K	﹤0.01%	2480
2019 Q1	$227K	Hold	2,605	–	–	﹤0.01%	2373
2018 Q4	$260K	Hold	2,605	–	–	﹤0.01%	2129
2018 Q3	$298K	Sell	2,605 -170	-6%	-$17.6K	﹤0.01%	2166
2018 Q2	$249K	Buy	+2,775	New	+$234K	﹤0.01%	2287

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services's HAE Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Haemonetics (HAE) stake by 3.2% in Q2 2026, selling an estimated $10.1K and leaving 4,789 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Commonwealth Equity Services first reported a position in HAE in Q2 2018 and has held it in 17 quarters since. The position peaked at $3.72M in Q2 2021. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Commonwealth Equity Services held 4,789 shares of Haemonetics worth $359K as of Q2 2026.
Commonwealth Equity Services sold 157 Haemonetics shares in Q2 2026, an estimated $10.1K.
Haemonetics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3611 holding.
Commonwealth Equity Services first reported a position in Haemonetics in Q2 2018 and has held it in 17 quarters since.
Commonwealth Equity Services's Haemonetics position peaked at $3.72M in Q2 2021.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.